Evidence & citations 4 cited values
Every value below carries the sentence it was read from.
1 source stands behind the page.
| Field | Value | Cited text |
|---|
| Known as |
ST-920 |
ClinicalTrials.gov intervention name — accepted as the source's own label NCT04046224 ↗
|
| Action |
Restore |
“ST-920 aims to provide stable, long-term production of α-Gal A at therapeutic levels” NCT04046224 ↗
|
| Modality |
Gene therapy (AAV / viral vector) |
“an adeno-associated virus (AAV2/6) vector encoding the complementary deoxyribonucleic acid (cDNA) for human a-Gal A” NCT04046224 ↗
|
| Route |
Intravenous |
“patients will be infused intravenously with a single dose of ST-920” NCT04046224 ↗
|